COMMUNIQUÉS West-GlobeNewswire
-
Weight Watchers and FlavCity Announce Collaboration Focused on Strength, Nutrition, and Community
08/07/2026 -
SRX Global Declares One-Time Cash Dividend
08/07/2026 -
Global Alzheimer’s Platform Foundation Announces Strategic Partnership with Taudia for the Transformative Bio-Hermes-002 Study
08/07/2026 -
Philips introduces Alturion ultrasound system with AI-powered workflows for high-volume clinical environments
08/07/2026 -
American Physical Therapy Association and Inteleos Activate Partnership with First Joint Educational Program for Musculoskeletal Ultrasound Imaging Standards and Certification
08/07/2026 -
Tekton Research and Summit Clinical Research Solutions Expand Partnership, Bring MASH Trials to Ohio
08/07/2026 -
Ultragenyx Releases 2025 Impact Report Emphasizing Commitment to Rare Disease Patients, Innovation, and Global Impact
08/07/2026 -
NewcelX Appoints World-Renowned Diabetes Cure-Focused Pioneer, Dr. Camillo Ricordi, to Scientific Advisory Board
08/07/2026 -
MAIA Biotechnology Reports Strong Initial Efficacy Data in Third-Line Non-Small Cell Lung Cancer from Phase 2 THIO-101 Part C Expansion Trial
08/07/2026 -
As America Celebrates its 250th Birthday, Becoming Independent Marks 59 Years of Helping People Live on Their Own Terms
08/07/2026 -
Cerene® Cryotherapy Announces Know Your Flow Event Series To Empower Women Through Free Menstrual and Perimenopause Education
08/07/2026 -
Une première mondiale : le protocole de traitement par cellules souches en une seule séance du KFSH de Djeddah établit une nouvelle référence en matière de sécurité des donneurs et d’efficacité thérapeutique
08/07/2026 -
Nonprofit Launches One of the Nation’s Most Comprehensive Education Resources for Inherited Retinal Diseases
08/07/2026 -
J-Star Holding Holding Co., Ltd Announces 1-for-5 Share Consolidation
08/07/2026 -
Satellos Reports Six-Month Interim TRAILHEAD Data Showing Reduced Muscle Fat Fraction, Increased Effort, Stable Strength, Lower CK and Favorable Safety Profile in DMD Adults Treated with SAT-3247
08/07/2026 -
Seres Therapeutics Announces Early Clinical Data Showing Potential for SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis (irEC), a Frequent Adverse Reaction That Forces Many Patients to Halt Cancer Treatment
08/07/2026 -
Shopify to Announce Second-Quarter 2026 Financial Results
08/07/2026 -
Seer Board of Directors Issues Letter to Shareholders Demonstrating the Strength and Experience of Seer’s Director Nominees
08/07/2026 -
OKYO Pharma Reports Positive Feedback from FDA Type D Meeting and Accelerates Urcosimod into Global Phase 3 Pivotal Trial for Neuropathic Corneal Pain
08/07/2026
Pages